MEDINET Co., Ltd. (TYO:2370)
Japan · Delayed Price · Currency is JPY 25.00
0.00 (0.00%)
Aug 27, 2026, 1:14 PM JST
MEDINET Market Cap
MEDINET has a market cap or net worth of 7.07 billion as of August 26, 2026. Its market cap has decreased by -29.75% in one year.
Market Cap
7.07B
Enterprise Value
n/a
Revenue
998.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.00
ChartMarket Cap Chart
Since December 20, 2005, MEDINET's market cap has decreased from 41.58B to 7.07B, a decrease of -83.00%. That is a compound annual growth rate of -8.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 7.07B | -7.95% |
| Dec 30, 2025 | 7.68B | -19.38% |
| Dec 30, 2024 | 9.52B | -11.95% |
| Dec 29, 2023 | 10.81B | -28.06% |
| Dec 30, 2022 | 15.03B | 64.34% |
| Dec 30, 2021 | 9.15B | -8.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 8.57B |
| Carna Biosciences | 8.52B |
| StemCell Institute | 7.80B |
| BrightPath Biotherapeutics | 7.36B |
| CellSource | 7.07B |
| ADR Biomedical Holdings | 6.82B |
| Chiome Bioscience | 6.63B |
| Chordia Therapeutics | 6.34B |